03 Mar 2013 @ 21:18
Growth concerns grow following $85bn of “dumb, arbitrary” cuts implemented after political stalemate President Obama has signed into law federal spending cuts worth $85bn, after the Democratic and Republican parties failed to reach agreement on how to balance the nation’s finances. Known as the sequester the spending cuts, described by the President as being “dumb” […]
25 Feb 2013 @ 14:19
FEI Company (
NASDAQ:FEIC)- The company is a supplier for scientific instruments for nanoscale imaging analysis and prototyping that enables research development and manufacturing in industrial academic and research institutional applications.
22 Feb 2013 @ 13:47
Ford Motor Co.(
NYSE:F)- Ford Motor Company engages in the development, manufacture, distribution, and service of vehicles and related parts worldwide. The company operates through two sectors, Automotive and Financial Services.
21 Feb 2013 @ 16:23
ConocoPhillips (
NYSE:COP) – Conocophilps explores, produces, transports and markets crude oil natural gas natural gas liquids liquidities natural gas and bitumen on a worldwide basis. Company has activities in 30 countries.
15 Feb 2013 @ 15:23
One of the biggest stories doing the round on Wall Street these days is that Dell Inc. (
NASDAQ:DELL), the Texas-based tech giant is going private. In this article I will be focussing about the Dell Buyout, starting with the Dell story over the years, then moving towards why is Dell going private, who are the […]
11 Feb 2013 @ 15:31
US Airways Group Inc. (
NYSE:LCC): The stock is moving on the news of its impending merger with American Airlines. The announcement is expected to be made within this week.
08 Feb 2013 @ 17:09
BlackBerry (
NASDAQ:BBRY): Consequent to the launch of its new BB10 devices, the company has received a spate of upgrades. Wells Fargo upped its recommendation for the stock from Market Perform to Outperform.
07 Feb 2013 @ 16:12
AstraZeneca Plc (
NYSE:AZN): The pharma company offers 5.83 percent dividend yield, making it an attractive income stock. AstraZeneca is likely to keep performing well despite posting weak results for the fiscal fourth quarter. The company‘s net profit for the quarter dropped to $6.3 billion while it revenue stood at $28 billion.
07 Feb 2013 @ 15:41
GlaxoSmithKline (
LSE:GSK) may be the perfect example of how investors should look at pharmaceutical companies differently than others. The company share price has remained relatively unchanged in the 1450.0 areas since 29 January, despite reporting “flat” sales for the full year ending 31 December 2012 on 06 February. Shares have dropped modestly today by 0.90% […]
06 Feb 2013 @ 16:12
CVS Caremark Corporation (
NYSE:CVS): The company reported 6 percent increase in its profits for the fourth quarter. CVS Caremark earned 90 cents per share, up from 81 cents per share it had earned in the corresponding quarter of the last year. Its revenue also increased 11 percent to $31.39 billion.